LCL161

Item no.	M4801-5mg
Manufacturer	AbMole
CASRN	1005342-46-0
Amount	5mg
Category	Oncology Neuroscience Aging & Neurological Disorders Inhibitors & Compound Libraries Small Molecules By Organ Breast Cancer Heart & Blood Cancer
Type	Inhibitors
Specific against	other
Purity	0,997
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	LCL-161
Available
Target Information	IAP
Molecular Weight	500, 63
Solubility	DMSO: 100 mg/mL
Bioactivity information	LCL161 is an orally bioavailable SMAC mimetic, potently binds to and inhibits multiple IAPs (i.e. XIAP, c-IAP).

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M4801-5mg-safety-datasheet.pdf